Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
Ganapati
R
R
Pai
V V
VV
Shroff
H J
HJ
Gandewar
K
K
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003140:Communicable Disease Control; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy* / Q000382:microbiology; D015440:Leprosy, Lepromatous / Q000188:drug therapy* / Q000382:microbiology; D015242:Ofloxacin / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D012867:Skin / Q000382:microbiology; D014944:World Health Organization
D000890:Anti-Infective Agents; D007917:Leprostatic Agents; D015242:Ofloxacin; D012293:Rifampin